Braskem (BAK) Liabilities and Shareholders Equity (2009 - 2025)

Braskem (BAK) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $15.2 billion the latest figure, recorded in Q4 2025.

• Quarterly Liabilities and Shareholders Equity fell 13.11% year-over-year to $15.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.6 billion (up 23.66% YoY) and the FY2025 annual result came in at $15.2 billion, down 13.11% from the prior year.
• Liabilities and Shareholders Equity slipped to $15.2 billion in Q4 2025 per BAK's latest filing, from $16.3 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for BAK reached as high as $18.7 billion in Q2 2024 and fell as low as $15.2 billion in Q4 2025.
• A 5-year average of $17.2 billion and a median of $17.1 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity gained 10.72% — and 2025, when it fell 13.11%.
• Year by year, Liabilities and Shareholders Equity stood at $16.6 billion in 2021, then increased by 0.86% to $16.7 billion in 2022, then gained by 10.72% to $18.5 billion in 2023, then declined by 5.68% to $17.5 billion in 2024, then declined by 13.11% to $15.2 billion in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $15.2 billion, $16.3 billion, and $17.5 billion for Q4 2025, Q1 2025, and Q4 2024 respectively.